These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 25499154)

  • 21. Utility of antiepileptic drug monitoring in the pediatric emergency department.
    Kozer E; Scolnik D; Agamata WM; Weiss SK; Verjee ZH; Koren G
    Ther Drug Monit; 2003 Feb; 25(1):17-21. PubMed ID: 12548139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epilepsy emergencies: the first seizure and status epilepticus.
    Willmore LJ
    Neurology; 1998 Nov; 51(5 Suppl 4):S34-8. PubMed ID: 9818922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value of therapeutic drug level monitoring and unbound (free) levels.
    Chan K; Beran RG
    Seizure; 2008 Sep; 17(6):572-5. PubMed ID: 18262440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiepileptic drugs--best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies.
    Patsalos PN; Berry DJ; Bourgeois BF; Cloyd JC; Glauser TA; Johannessen SI; Leppik IE; Tomson T; Perucca E
    Epilepsia; 2008 Jul; 49(7):1239-76. PubMed ID: 18397299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiepileptic drugs: generic versus branded treatments.
    Heaney DC; Sander JW
    Lancet Neurol; 2007 May; 6(5):465-8. PubMed ID: 17434101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current issues in the treatment of epilepsy.
    Pugh CB; Garnett WR
    Clin Pharm; 1991 May; 10(5):335-58. PubMed ID: 2049897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrapatient variation in antiepileptic drug plasma concentration after generic substitution vs stable brand-name drug regimens.
    Contin M; Alberghini L; Candela C; Benini G; Riva R
    Epilepsy Res; 2016 May; 122():79-83. PubMed ID: 26987080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monitoring for adverse effects of antiepileptic drugs.
    Camfield P; Camfield C
    Epilepsia; 2006; 47 Suppl 1():31-4. PubMed ID: 17044823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brand name to generic substitution of antiepileptic drugs does not lead to seizure-related hospitalization: a population-based case-crossover study.
    Polard E; Nowak E; Happe A; Biraben A; Oger E;
    Pharmacoepidemiol Drug Saf; 2015 Nov; 24(11):1161-9. PubMed ID: 26395769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of antiepileptic drug tapering in the pediatric epilepsy monitoring unit.
    Keller AE; Bradbury L; Wang L; Yau I; Donner EJ
    Epilepsy Behav; 2018 Oct; 87():83-88. PubMed ID: 30131223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Updated Overview on Therapeutic Drug Monitoring of Recent Antiepileptic Drugs.
    Jacob S; Nair AB
    Drugs R D; 2016 Dec; 16(4):303-316. PubMed ID: 27766590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategies for successful management of older patients with seizures.
    Eisenschenk S; Gilmore R
    Geriatrics; 1999 Dec; 54(12):31, 34, 39-40 passim. PubMed ID: 10605434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lacosamide serum concentrations in adult patients with epilepsy: the influence of gender, age, dose, and concomitant antiepileptic drugs.
    Markoula S; Teotonio R; Ratnaraj N; Duncan JS; Sander JW; Patsalos PN
    Ther Drug Monit; 2014 Aug; 36(4):494-8. PubMed ID: 24562047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lacosamide therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs.
    Contin M; Albani F; Riva R; Candela C; Mohamed S; Baruzzi A
    Ther Drug Monit; 2013 Dec; 35(6):849-52. PubMed ID: 23942540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seizures in patients with idiopathic hypoparathyroidism: effect of antiepileptic drug withdrawal on recurrence of seizures and serum calcium control.
    Modi S; Tripathi M; Saha S; Goswami R
    Eur J Endocrinol; 2014 May; 170(5):777-83. PubMed ID: 24648439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controversies in blood-level monitoring: reexamining its role in the treatment of epilepsy.
    Glauser TA; Pippenger CE
    Epilepsia; 2000; 41 Suppl 8():S6-15. PubMed ID: 11092608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic Drug Monitoring of Newer Antiepileptic Drugs: A Randomized Trial for Dosage Adjustment.
    Aícua-Rapún I; André P; Rossetti AO; Ryvlin P; Hottinger AF; Decosterd LA; Buclin T; Novy J
    Ann Neurol; 2020 Jan; 87(1):22-29. PubMed ID: 31714640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An evaluation of factors affecting adherence to antiepileptic drugs in patients with epilepsy: a cross-sectional study.
    Gurumurthy R; Chanda K; Sarma G
    Singapore Med J; 2017 Feb; 58(2):98-102. PubMed ID: 26805666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early withdrawal of non-anesthetic antiepileptic drugs after successful termination of nonconvulsive seizures and nonconvulsive status epilepticus.
    Creed JA; Son J; Farjat AE; Swisher CB
    Seizure; 2018 Jan; 54():45-50. PubMed ID: 29248799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The economic implications of generic substitution of antiepileptic drugs: a review of recent evidence.
    Duh MS; Cahill KE; Paradis PE; Cremieux PY; Greenberg PE
    Expert Opin Pharmacother; 2009 Oct; 10(14):2317-28. PubMed ID: 19663636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.